 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This price move could indicate a change in the trend, and may be a buy signal for investors...

SI-BONE (SIBN, $18.65) price moved above its 50-day Moving Average on December 07, 2023

Needham  Company LLC reiterated their buy rating on shares of SI-BONE (NASDAQ:SIBN  Free Report) in a research report released on Monday, Benzinga reports. Needham  Company LLC...

SI-BONE (NASDAQ:SIBN) Receives "Buy" Rating from Needham & Company LLC

Latest Ratings for SIBN
 DateFirmActionFromTo Mar 2022Morgan StanleyMaintainsOverweight Jan 2022B of A SecuritiesMaintainsBuy Dec 2021Truist SecuritiesMaintainsBuy
 View More Analyst Ratings for...

What 5 Analyst Ratings Have To Say About SI-BONE

SI-BONE (SIBN, $18.98) price moved above its 50-day Moving Average on November 30, 2023

Insider Sell: President, Commercial Ops Anthony Recupero Sells 8,457 Shares of SI-BONE Inc (SIBN)

This indicator may be signaling SIBN's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

SI-BONE (SIBN, $18.04) entered Uptrend as Momentum indicator ascends above 0 level on Nov 20, 2023

This indicator may be signaling that SIBN's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

SI-BONE (SIBN, $17.54) entered Downtrend as Momentum indicator drops below 0 level on Nov 17, 2023

This is a signal that SIBN's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

SI-BONE (SIBN, $17.67) Stochastic Oscillator left the overbought zone on November 16, 2023

Investors eyeing a purchase of SI-BONE Inc (SIBN) shares, but tentative about paying the going market price of 17.71/share, might benefit from considering selling puts among the alternative...

Commit To Buy SI-BONE At $17.50, Earn 19.1% Annualized Using Options

SI-BONE (SIBN, $17.44) entered Uptrend as Momentum indicator ascends above 0 level on Nov 14, 2023

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.

Watchers	179
52-Wk Low	$11.23
52-Wk High	$29.51

Market Cap	$755.34M
Volume (M)	478,606.00
52-Wk High	$29.51
52-Wk Low	$11.23

Current Price	$18.65
Prev Close	$17.80
Open	$17.80
Dividend Yield	0.00%
50-Day Moving Average	$18.09
Beta	1.31
Avg. Volume	399,805.38
PE Ratio	-15.72

52-Week High	$29.51
52-Week Low	$11.23
Market Capitalization	$755.34M
EPS	-$1.19
Price to Book	4.34
Revenue Per Employee	$369,691.88
Enterprise Value/EBITDA	-17.78

SIBN SI-BONE Inc

About

Feed

News

Sentiment

Earnings

Fundamentals